Results 101 to 110 of about 3,273 (206)

PsychoPharm aggregated risk score (PARS): a multidimensional tool to flag high-risk pharmacotherapy in psychiatric patients. [PDF]

Front Pharmacol
Goldiş FD, Vasii SO, Ardelean SM, Udrescu-Milosav M, Udrescu L.   +4 more
europepmc   +1 more source

X-Linked Hypophosphatemia in a Family Cohort: Clinical Variability, Genetic Confirmation and Modern Therapeutic Perspectives. [PDF]

J Clin Med
Popa O, Balaș M, Golu I, Amzăr D, Dorogi C, Vlad M.   +5 more
europepmc   +1 more source

Alfacalcidol and hypercalcaemia. [PDF]

BMJ, 1987
openaire   +2 more sources

Deciphering the causal relationships between plasma metabolites, peripheral cells, inflammatory factors and DLBCL for discovering novel therapeutic targets. [PDF]

Discov Oncol
Xu M, Xu L, Zhu W, Ruan M, Xu J, Qu Y, Wang L, Zhu W.   +7 more
europepmc   +1 more source

Effect of Vitamin D Supplementation on Total Knee Arthroplasty Outcomes: A Systematic Review. [PDF]

Orthop J Sports Med
Vosoughi F, Ayati Firoozabadi A, Amiri A, Menbari Oskuie I.   +3 more
europepmc   +1 more source

Hypercalcemia in Patients After Kidney Transplantation. [PDF]

Cureus
Miedziaszczyk M, Lacka K, Bajon A, Lewandowski D, Kamalska M, Zelga P, Swiatek L, Karczewski M, Idasiak-Piechocka I.   +8 more
europepmc   +1 more source

Iatrogenic neonatal hyperphosphatemia due to phosphate-containing enema. [PDF]

Endocrinol Diabetes Metab Case Rep
Nauwynck E, Vanbesien J, Staels W, Gies I, De Cuyper C, Huysentruyt K, Mauel R, De Schepper J.   +7 more
europepmc   +1 more source

Comparative efficacy and safety of odanacatib, abaloparatide, denosumab, teriparatide, and bisphosphonates for male osteoporosis: a systematic review and network meta-analysis. [PDF]

Front Endocrinol (Lausanne)
Lu C, Zhang L, Xue C, Liao M, Fei J, Chen X, Wang L.   +6 more
europepmc   +1 more source

Osteoporosis: Correction with Alfacalcidol

Research, 2016
A E Lychkova, A M Puzikov
openaire   +1 more source

Efficacy of Alfacalcidol Versus Calcitriol in Managing Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease. [PDF]

Hosp Pharm
El Nekidy WS, Ghazal I, Mallat J, Abidi E, Malik A, Madhyastha R, Hijazi F, Ghosn M.   +7 more
europepmc   +1 more source